Macular Laser Photocoagulation

PROCEDURE4 trials

Sponsors

Seoul Retina Investigator Group, Regeneron Pharmaceuticals, Bayer

Conditions

Branch Retinal Vein OcclusionDiabetic Macular EdemaMacular Edema

Phase 3

Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)

Seoul Retina Investigator GroupBranch Retinal Vein Occlusion

Start: 2009-01-31End: 2011-08-31Target: 60Updated: 2010-08-26

Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema

CompletedNCT01363440

Regeneron PharmaceuticalsDiabetic Macular Edema

Start: 2011-05-31End: 2014-11-30Updated: 2016-05-30

Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)

CompletedNCT01521559

Regeneron PharmaceuticalsBranch Retinal Vein Occlusion

Start: 2012-04-30End: 2014-03-31Updated: 2014-11-13

Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement

CompletedNCT01783886

BayerMacular Edema

Start: 2013-02-28End: 2015-03-31Updated: 2016-05-12

Related Papers

Expanding insights from the VISTA phase III trial: longitudinal comparative assessment of ellipsoid zone integrity and volumetric fluid dynamics.

2025-12-05

Clinically Meaningful Change Estimates for the National Eye Institute Visual Function Questionnaire-25 in Patients With Diabetic Macular Edema.

2024-12-01

Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials

Journal of VitreoRetinal Diseases2022-06-042 citations

Functional outcomes of sustained improvement on Diabetic Retinopathy Severity Scale with intravitreal aflibercept in the VISTA and VIVID trials

Eye2022-04-192 citations

<p>Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study</p>

Clinical ophthalmology2020-03-0113 citations

Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies

Journal of Ophthalmology2018-01-0112 citations

Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies

British Journal of Ophthalmology2017-10-1923 citations

Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema

JAMA Ophthalmology2016-12-2214 citations

Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data.

2016-07-1128 citations

Intravitreal Aflibercept Has Long-Term Benefits in Treatment of DME

MD Conference Express2014-12-01